title: Is there a relationship between ELF free-IGF-1 levels and fibrotic process enhancement characterizing CLD development in neutropenic premature babies?
authors.forename: Ettore
authors.initials: E
authors.lastname: Capoluongo
authors.forename: Paola
authors.initials: P
authors.lastname: Concolino
authors.forename: Bruno
authors.initials: B
authors.lastname: Giardina
authors.forename: Cecilia
authors.initials: C
authors.lastname: Zuppi
authors.forename: Franco
authors.initials: F
authors.lastname: Ameglio
authors.forename: Giovanni
authors.initials: G
authors.lastname: Vento
authors.forename: Costantino
authors.initials: C
authors.lastname: Romagnoli
mesh_terms: D015415:Biomarkers / Q000032:analysis; D001997:Bronchopulmonary Dysplasia / Q000097:blood / Q000175:diagnosis*; D018450:Disease Progression; D036383:Ephrin-A2 / Q000378:metabolism*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000175:diagnosis; D011658:Pulmonary Fibrosis / Q000097:blood / Q000175:diagnosis*; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood / Q000175:diagnosis*; D012178:Retinopathy of Prematurity / Q000097:blood / Q000175:diagnosis; D012494:Sampling Studies; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; D036383:Ephrin-A2; D007334:Insulin-Like Growth Factor I